Valuation: Vivos Therapeutics, Inc.

Market Cap 3.24M 2.82M 2.67M 2.43M 4.53M 311M 4.56M 31.81M 12.3M 158M 12.17M 11.9M 505M P/E 2026 *
-0.12x
P/E 2027 * -0.2x
Enterprise Value 3.24M 2.82M 2.67M 2.43M 4.53M 311M 4.56M 31.81M 12.3M 158M 12.17M 11.9M 505M EV / Sales 2026 *
0.15x
EV / Sales 2027 * 0.1x
Free-Float
88%
Yield 2026 *
-
Yield 2027 * -
1 day+9.25%
1 week+3.41%
Current month-10.20%
1 month-48.73%
3 months-67.68%
6 months-86.46%
Current year-91.33%
1 week 0.16
Extreme 0.1559
0.19
1 month 0.16
Extreme 0.1559
0.46
Current year 0.16
Extreme 0.1559
2.69
1 year 0.16
Extreme 0.1559
3.61
3 years 0.16
Extreme 0.1559
48.79
5 years 0.16
Extreme 0.1559
121
10 years 0.16
Extreme 0.1559
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 01/09/2016
Chief Executive Officer 68 01/09/2016
Director TitleAgeSince
Chairman 68 01/06/2020
Director/Board Member 87 01/06/2020
Director/Board Member 59 01/06/2020
Date Insider Type Main position Quantity % Market Cap. Importance
31/07/26 Free

Chief Financial Officer

400,000 2.8788%
30/06/26
Seneca Partners, Inc.
BuyCompany 2,749,330 19.7870%
30/06/26
Seneca Partners, Inc.
OtherCompany 2,749,330 19.7870%
Change 5-day change 1-year change 3-year change Capi.($)
+9.25%+3.41%-94.82%-97.13% 3.24M
+0.15%-0.22%+21.26%+19.16% 12.54B
-0.62%+0.25%+12.97%+19.11% 6.69B
-1.65%-3.21% - - 6.3B
+0.34%+0.64%+23.73%+10.51% 5.6B
+0.37%+1.89%-18.21%+38.13% 5.04B
+0.73%+1.56%-33.36%-24.76% 3.85B
+3.08%+6.97%+31.86%-13.37% 1.89B
+0.17%+1.34%+0.66%+185.18% 1.75B
+0.49%-0.16%+48.26%-16.10% 1.61B
Average +1.23%+0.15%-0.85%+13.42% 4.53B
Weighted average by Cap. +0.02%+0.32%+10.39%+20.45%

Financials

2026 *2027 *
Net sales 21.79M 18.98M 17.96M 16.31M 30.48M 2.09B 30.65M 214M 82.67M 1.06B 81.82M 80.02M 3.4B 34.09M 29.7M 28.1M 25.51M 47.68M 3.27B 47.95M 335M 129M 1.66B 128M 125M 5.31B
Net income -23.53M -20.5M -19.4M -17.61M -32.92M -2.26B -33.1M -231M -89.29M -1.14B -88.37M -86.42M -3.67B -14.7M -12.81M -12.12M -11.01M -20.57M -1.41B -20.68M -144M -55.79M -715M -55.22M -54M -2.29B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
268
Date Price Change Volume
17/09/26 $0.1760 +9.25% 1,796,193
16/09/26 $0.1611 -1.53% 1,366,101
15/09/26 $0.1636 -7.41% 1,558,577
14/09/26 $0.1767 -3.97% 1,137,150
11/09/26 $0.1840 +1.32% 1,521,136
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.1760USD
Average target price
2.117USD
Spread / Average Target
+1,102.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!